Click here to get full coverage on If You Invested $1,000 in Foghorn Therapeutics Inc. (FHTX) - Stock Titan

If You Invested $1,000 in Foghorn Therapeutics Inc. (FHTX)  Stock Titan

If You Invested $1,000 in Foghorn Therapeutics Inc. (FHTX) - Stock Titan

Click here to get full coverage on Foghorn Therapeutics Inc. (NASDAQ:FHTX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Foghorn Therapeutics Inc. (NASDAQ:FHTX) Receives Consensus Rating of "Moderate Buy" from Brokerages  MarketBeat

Foghorn Therapeutics Inc. (NASDAQ:FHTX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Click here to get full coverage on FHTX Stock Price, Quote & Chart | FOGHORN THERAPEUTICS INC (NASDAQ:FHTX) - ChartMill

FHTX Stock Price, Quote & Chart | FOGHORN THERAPEUTICS INC (NASDAQ:FHTX)  ChartMill

FHTX Stock Price, Quote & Chart | FOGHORN THERAPEUTICS INC (NASDAQ:FHTX) - ChartMill

Click here to get full coverage on Foghorn Therapeutics Inc. (FHTX) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance

Foghorn Therapeutics Inc. (FHTX) Reports Q4 Loss, Beats Revenue Estimates  Yahoo Finance

Foghorn Therapeutics Inc. (FHTX) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance

Click here to get full coverage on Here's Why We're Watching Foghorn Therapeutics' (NASDAQ:FHTX) Cash Burn Situation - simplywall.st

Here's Why We're Watching Foghorn Therapeutics' (NASDAQ:FHTX) Cash Burn Situation  simplywall.st

Here's Why We're Watching Foghorn Therapeutics' (NASDAQ:FHTX) Cash Burn Situation - simplywall.st

Click here to get full coverage on Strength seen in Dianthus Therapeutics, Inc. (DNTH): Can its 5.6% jump turn into more strength? - MSN

Strength seen in Dianthus Therapeutics, Inc. (DNTH): Can its 5.6% jump turn into more strength?  MSN

Strength seen in Dianthus Therapeutics, Inc. (DNTH): Can its 5.6% jump turn into more strength? - MSN

Click here to get full coverage on Foghorn Therapeutics Inc. Secures $50 Million in Equity Financing to Advance Oncology Pipeline and Strengthen Balance Sheet | FHTX Stock News - Quiver Quantitative

Foghorn Therapeutics Inc. Secures $50 Million in Equity Financing to Advance Oncology Pipeline and Strengthen Balance Sheet | FHTX Stock News  Quiver Quantitative

Foghorn Therapeutics Inc. Secures $50 Million in Equity Financing to Advance Oncology Pipeline and Strengthen Balance Sheet | FHTX Stock News - Quiver Quantitative

Click here to get full coverage on FHTX Apr 2026 7.500 call (FHTX260417C00007500) stock price, news, quote and history - Yahoo Finance Singapore

FHTX Apr 2026 7.500 call (FHTX260417C00007500) stock price, news, quote and history  Yahoo Finance Singapore

FHTX Apr 2026 7.500 call (FHTX260417C00007500) stock price, news, quote and history - Yahoo Finance Singapore

Click here to get full coverage on Cancer drug developer Foghorn raises $50M, funds work on hard-to-treat tumors - Stock Titan

Cancer drug developer Foghorn raises $50M, funds work on hard-to-treat tumors  Stock Titan

Cancer drug developer Foghorn raises $50M, funds work on hard-to-treat tumors - Stock Titan

Click here to get full coverage on Is Foghorn Therapeutics (NASDAQ:FHTX) In A Good Position To Deliver On Growth Plans? - Yahoo Finance

Is Foghorn Therapeutics (NASDAQ:FHTX) In A Good Position To Deliver On Growth Plans?  Yahoo Finance

Is Foghorn Therapeutics (NASDAQ:FHTX) In A Good Position To Deliver On Growth Plans? - Yahoo Finance

Click here to get full coverage on FHTX Apr 2026 2.500 put (FHTX260417P00002500) interactive stock chart - Yahoo Finance Singapore

FHTX Apr 2026 2.500 put (FHTX260417P00002500) interactive stock chart  Yahoo Finance Singapore

FHTX Apr 2026 2.500 put (FHTX260417P00002500) interactive stock chart - Yahoo Finance Singapore

Click here to get full coverage on Foghorn Therapeutics (FHTX): Forecast 28.8% Revenue Growth Challenges Ongoing Loss Narrative - Yahoo Finance

Foghorn Therapeutics (FHTX): Forecast 28.8% Revenue Growth Challenges Ongoing Loss Narrative  Yahoo Finance

Foghorn Therapeutics (FHTX): Forecast 28.8% Revenue Growth Challenges Ongoing Loss Narrative - Yahoo Finance

Click here to get full coverage on FHTX Apr 2026 7.500 call (FHTX260417C00007500) interactive stock chart - Yahoo Finance Singapore

FHTX Apr 2026 7.500 call (FHTX260417C00007500) interactive stock chart  Yahoo Finance Singapore

FHTX Apr 2026 7.500 call (FHTX260417C00007500) interactive stock chart - Yahoo Finance Singapore

Click here to get full coverage on Foghorn Therapeutics (FHTX) Upgraded to Buy: Here's Why - Yahoo Finance

Foghorn Therapeutics (FHTX) Upgraded to Buy: Here's Why  Yahoo Finance

Foghorn Therapeutics (FHTX) Upgraded to Buy: Here's Why - Yahoo Finance

Click here to get full coverage on Ajit Singh Appointed CEO of Harbinger Health and CEO-Partner of Flagship Pioneering - PR Newswire

Ajit Singh Appointed CEO of Harbinger Health and CEO-Partner of Flagship Pioneering  PR Newswire

Ajit Singh Appointed CEO of Harbinger Health and CEO-Partner of Flagship Pioneering - PR Newswire

Click here to get full coverage on Foghorn Therapeutics Strengthens Financial Leadership with Appointment of Ryan Maynard as Chief Financial Officer - GlobeNewswire

Foghorn Therapeutics Strengthens Financial Leadership with Appointment of Ryan Maynard as Chief Financial Officer  GlobeNewswire

Foghorn Therapeutics Strengthens Financial Leadership with Appointment of Ryan Maynard as Chief Financial Officer - GlobeNewswire

Click here to get full coverage on Foghorn Therapeutics (NASDAQ:FHTX) Earns "Outperform" Rating from Wedbush - MarketBeat

Foghorn Therapeutics (NASDAQ:FHTX) Earns "Outperform" Rating from Wedbush  MarketBeat

Foghorn Therapeutics (NASDAQ:FHTX) Earns "Outperform" Rating from Wedbush - MarketBeat

Click here to get full coverage on Foghorn Therapeutics (NASDAQ:FHTX) Issues Quarterly Earnings Results, Misses Expectations By $0.04 EPS - MarketBeat

Foghorn Therapeutics (NASDAQ:FHTX) Issues Quarterly Earnings Results, Misses Expectations By $0.04 EPS  MarketBeat

Foghorn Therapeutics (NASDAQ:FHTX) Issues Quarterly Earnings Results, Misses Expectations By $0.04 EPS - MarketBeat

Click here to get full coverage on Foghorn Therapeutics Announces Closing of $50 Million Registered Direct Financing at a 30% Premium - GlobeNewswire

Foghorn Therapeutics Announces Closing of $50 Million Registered Direct Financing at a 30% Premium  GlobeNewswire

Foghorn Therapeutics Announces Closing of $50 Million Registered Direct Financing at a 30% Premium - GlobeNewswire

Click here to get full coverage on Biotech CFO who raised $1B in deals joins Foghorn Therapeutics - Stock Titan

Biotech CFO who raised $1B in deals joins Foghorn Therapeutics  Stock Titan

Biotech CFO who raised $1B in deals joins Foghorn Therapeutics - Stock Titan

Click here to get full coverage on Stifel reiterates Foghorn Therapeutics stock rating at buy - Investing.com

Stifel reiterates Foghorn Therapeutics stock rating at buy  Investing.com

Stifel reiterates Foghorn Therapeutics stock rating at buy - Investing.com

Click here to get full coverage on Flagship Pioneering Appoints Rahul Kakkar as CEO-Partner and CEO of Quotient Therapeutics - PR Newswire

Flagship Pioneering Appoints Rahul Kakkar as CEO-Partner and CEO of Quotient Therapeutics  PR Newswire

Flagship Pioneering Appoints Rahul Kakkar as CEO-Partner and CEO of Quotient Therapeutics - PR Newswire

Click here to get full coverage on Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences - GlobeNewswire

Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences  GlobeNewswire

Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences - GlobeNewswire

Click here to get full coverage on Foghorn Therapeutics Inc. Appoints Ryan Maynard as Chief Financial Officer - Quiver Quantitative

Foghorn Therapeutics Inc. Appoints Ryan Maynard as Chief Financial Officer  Quiver Quantitative

Foghorn Therapeutics Inc. Appoints Ryan Maynard as Chief Financial Officer - Quiver Quantitative

Click here to get full coverage on Jefferies initiates Foghorn Therapeutics stock with buy rating - Investing.com

Jefferies initiates Foghorn Therapeutics stock with buy rating  Investing.com

Jefferies initiates Foghorn Therapeutics stock with buy rating - Investing.com

Click here to get full coverage on Foghorn earnings missed by $0.02, revenue fell short of estimates - Investing.com

Foghorn earnings missed by $0.02, revenue fell short of estimates  Investing.com

Foghorn earnings missed by $0.02, revenue fell short of estimates - Investing.com

Click here to get full coverage on B.Riley Financial Initiates Foghorn Therapeutics(FHTX.US) With Buy Rating, Announces Target Price $10 - 富途牛牛

B.Riley Financial Initiates Foghorn Therapeutics(FHTX.US) With Buy Rating, Announces Target Price $10  富途牛牛

B.Riley Financial Initiates Foghorn Therapeutics(FHTX.US) With Buy Rating, Announces Target Price $10 - 富途牛牛

Click here to get full coverage on Citizens reiterates Foghorn Therapeutics stock rating on pipeline progress - Investing.com

Citizens reiterates Foghorn Therapeutics stock rating on pipeline progress  Investing.com

Citizens reiterates Foghorn Therapeutics stock rating on pipeline progress - Investing.com

Click here to get full coverage on Ted Myles Joins Cellarity as Chief Executive Officer - PR Newswire

Ted Myles Joins Cellarity as Chief Executive Officer  PR Newswire

Ted Myles Joins Cellarity as Chief Executive Officer - PR Newswire

Click here to get full coverage on BTIG initiates Foghorn Therapeutics stock with Buy rating on cancer pipeline - Investing.com

BTIG initiates Foghorn Therapeutics stock with Buy rating on cancer pipeline  Investing.com

BTIG initiates Foghorn Therapeutics stock with Buy rating on cancer pipeline - Investing.com

Click here to get full coverage on Foghorn Therapeutics Reports Progress in FHD-909 Phase 1 Trial and Pipeline Developments with Strong Financial Position - Quiver Quantitative

Foghorn Therapeutics Reports Progress in FHD-909 Phase 1 Trial and Pipeline Developments with Strong Financial Position  Quiver Quantitative

Foghorn Therapeutics Reports Progress in FHD-909 Phase 1 Trial and Pipeline Developments with Strong Financial Position - Quiver Quantitative

Click here to get full coverage on symbol__ Stock Quote Price and Forecast - CNN

symbol__ Stock Quote Price and Forecast  CNN

symbol__ Stock Quote Price and Forecast - CNN

Click here to get full coverage on FHTX Exceeds Revenue Expectations and Advances Pipeline Programs - GuruFocus

FHTX Exceeds Revenue Expectations and Advances Pipeline Programs  GuruFocus

FHTX Exceeds Revenue Expectations and Advances Pipeline Programs - GuruFocus

Click here to get full coverage on A*STAR and Flagship Pioneering Announce Partnership to Spur Biotech Innovation in Singapore - PR Newswire

A*STAR and Flagship Pioneering Announce Partnership to Spur Biotech Innovation in Singapore  PR Newswire

A*STAR and Flagship Pioneering Announce Partnership to Spur Biotech Innovation in Singapore - PR Newswire

Click here to get full coverage on Flagship Pioneering Announces Agreement Between Pioneering Medicines and Pfizer to Discover Potential Novel, Selective Inhibitors for Autoimmune Disease - PR Newswire

Flagship Pioneering Announces Agreement Between Pioneering Medicines and Pfizer to Discover Potential Novel, Selective Inhibitors for Autoimmune Disease  PR Newswire

Flagship Pioneering Announces Agreement Between Pioneering Medicines and Pfizer to Discover Potential Novel, Selective Inhibitors for Autoimmune Disease - PR Newswire

Click here to get full coverage on Flagship Pioneering, Cambridge University Health Partners, and Milner Therapeutics Institute Announce Collaboration to Accelerate Biotech Research and Innovation - PR Newswire

Flagship Pioneering, Cambridge University Health Partners, and Milner Therapeutics Institute Announce Collaboration to Accelerate Biotech Research and Innovation  PR Newswire

Flagship Pioneering, Cambridge University Health Partners, and Milner Therapeutics Institute Announce Collaboration to Accelerate Biotech Research and Innovation - PR Newswire

Click here to get full coverage on Flagship Pioneering Appoints Angela Hwang as CEO-Partner and Chief Executive Officer of Metaphore Biotechnologies - PR Newswire

Flagship Pioneering Appoints Angela Hwang as CEO-Partner and Chief Executive Officer of Metaphore Biotechnologies  PR Newswire

Flagship Pioneering Appoints Angela Hwang as CEO-Partner and Chief Executive Officer of Metaphore Biotechnologies - PR Newswire

Click here to get full coverage on Brian M. Alexander Joins Valo Health as Chief Executive Officer and Flagship Pioneering as CEO-Partner - PR Newswire

Brian M. Alexander Joins Valo Health as Chief Executive Officer and Flagship Pioneering as CEO-Partner  PR Newswire

Brian M. Alexander Joins Valo Health as Chief Executive Officer and Flagship Pioneering as CEO-Partner - PR Newswire

Click here to get full coverage on Flagship Pioneering and Quotient Therapeutics Announce Agreement to Identify Potential Novel Targets for the Treatment of Cardiovascular and Renal Diseases under Strategic Partnership with Pfizer - PR Newswire

Flagship Pioneering and Quotient Therapeutics Announce Agreement to Identify Potential Novel Targets for the Treatment of Cardiovascular and Renal Diseases under Strategic Partnership with Pfizer  PR Newswire

Flagship Pioneering and Quotient Therapeutics Announce Agreement to Identify Potential Novel Targets for the Treatment of Cardiovascular and Renal Diseases under Strategic Partnership with Pfizer - PR Newswire

Click here to get full coverage on Foghorn Therapeutics Inc. (FHTX) stock price, news, quote and history - Yahoo Finance UK

Foghorn Therapeutics Inc. (FHTX) stock price, news, quote and history  Yahoo Finance UK

Foghorn Therapeutics Inc. (FHTX) stock price, news, quote and history - Yahoo Finance UK

Click here to get full coverage on Flagship Pioneering Appoints Craig Williams as CEO-Partner and Chief Executive Officer of Apriori Bio - PR Newswire

Flagship Pioneering Appoints Craig Williams as CEO-Partner and Chief Executive Officer of Apriori Bio  PR Newswire

Flagship Pioneering Appoints Craig Williams as CEO-Partner and Chief Executive Officer of Apriori Bio - PR Newswire

Click here to get full coverage on Flagship Pioneering Announces Appointment of Paul Parker as Managing Partner, Leading Capital Solutions - PR Newswire

Flagship Pioneering Announces Appointment of Paul Parker as Managing Partner, Leading Capital Solutions  PR Newswire

Flagship Pioneering Announces Appointment of Paul Parker as Managing Partner, Leading Capital Solutions - PR Newswire

Click here to get full coverage on FHTX Stock Price and Chart — NASDAQ:FHTX - TradingView

FHTX Stock Price and Chart — NASDAQ:FHTX  TradingView

FHTX Stock Price and Chart — NASDAQ:FHTX - TradingView

Click here to get full coverage on Flagship Pioneering Unveils Mirai Bio to Provide Fully Integrated End-to-End Genetic Medicine Development Capabilities for the Biotech Industry - PR Newswire

Flagship Pioneering Unveils Mirai Bio to Provide Fully Integrated End-to-End Genetic Medicine Development Capabilities for the Biotech Industry  PR Newswire

Flagship Pioneering Unveils Mirai Bio to Provide Fully Integrated End-to-End Genetic Medicine Development Capabilities for the Biotech Industry - PR Newswire

Click here to get full coverage on Flagship Pioneering Announces Appointment of Raj Panjabi as Senior Partner - PR Newswire

Flagship Pioneering Announces Appointment of Raj Panjabi as Senior Partner  PR Newswire

Flagship Pioneering Announces Appointment of Raj Panjabi as Senior Partner - PR Newswire

Click here to get full coverage on Foghorn Therapeutics (FHTX) Investor Presentation - Slideshow (NASDAQ:FHTX) 2023-04-16 - Seeking Alpha

Foghorn Therapeutics (FHTX) Investor Presentation - Slideshow (NASDAQ:FHTX) 2023-04-16  Seeking Alpha

Foghorn Therapeutics (FHTX) Investor Presentation - Slideshow (NASDAQ:FHTX) 2023-04-16 - Seeking Alpha

Click here to get full coverage on What is the current Price Target and Forecast for Foghorn Therapeutics (FHTX) - Zacks Investment Research

What is the current Price Target and Forecast for Foghorn Therapeutics (FHTX)  Zacks Investment Research

What is the current Price Target and Forecast for Foghorn Therapeutics (FHTX) - Zacks Investment Research

Click here to get full coverage on Flagship Pioneering Unveils Terrana Biosciences to Deliver Adapt - GuruFocus

Flagship Pioneering Unveils Terrana Biosciences to Deliver Adapt  GuruFocus

Flagship Pioneering Unveils Terrana Biosciences to Deliver Adapt - GuruFocus

Click here to get full coverage on Foghorn Therapeutics Inc. (FHTX) stock price, news, quote and history - Yahoo Finance Singapore

Foghorn Therapeutics Inc. (FHTX) stock price, news, quote and history  Yahoo Finance Singapore

Foghorn Therapeutics Inc. (FHTX) stock price, news, quote and history - Yahoo Finance Singapore

Click here to get full coverage on Foghorn Therapeutics Inc. (FHTX) Stock Price, News, Quote & History - Yahoo! Finance Canada

Foghorn Therapeutics Inc. (FHTX) Stock Price, News, Quote & History  Yahoo! Finance Canada

Foghorn Therapeutics Inc. (FHTX) Stock Price, News, Quote & History - Yahoo! Finance Canada

Click here to get full coverage on Should I buy Foghorn Therapeutics (FHTX) - Zacks Investment Research

Should I buy Foghorn Therapeutics (FHTX)  Zacks Investment Research

Should I buy Foghorn Therapeutics (FHTX) - Zacks Investment Research

Click here to get full coverage on FHTX Forecast — Price Target — Prediction for 2027 - TradingView

FHTX Forecast — Price Target — Prediction for 2027  TradingView

FHTX Forecast — Price Target — Prediction for 2027 - TradingView

Click here to get full coverage on What date does Foghorn Therapeutics's (FHTX) report Earnings - Earnings Calendar & Announcement - Zacks Investment Research

What date does Foghorn Therapeutics's (FHTX) report Earnings - Earnings Calendar & Announcement  Zacks Investment Research

What date does Foghorn Therapeutics's (FHTX) report Earnings - Earnings Calendar & Announcement - Zacks Investment Research

Click here to get full coverage on Foghorn Therapeutics (FHTX) Stock Price, News & Analysis - MarketBeat

Foghorn Therapeutics (FHTX) Stock Price, News & Analysis  MarketBeat

Foghorn Therapeutics (FHTX) Stock Price, News & Analysis - MarketBeat

Click here to get full coverage on Foghorn Therapeutics (FHTX) Earnings Date and Reports 2026 - MarketBeat

Foghorn Therapeutics (FHTX) Earnings Date and Reports 2026  MarketBeat

Foghorn Therapeutics (FHTX) Earnings Date and Reports 2026 - MarketBeat

Click here to get full coverage on Analysts Predict Up to ~450% Surge for These 2 ‘Strong Buy’ Penny Stocks - Yahoo Finance

Analysts Predict Up to ~450% Surge for These 2 ‘Strong Buy’ Penny Stocks  Yahoo Finance

Analysts Predict Up to ~450% Surge for These 2 ‘Strong Buy’ Penny Stocks - Yahoo Finance

Click here to get full coverage on FHTX IPO News - Preclinical oncology biotech Foghorn Therapeutics sets terms for $120 million IPO - renaissancecapital.com

FHTX IPO News - Preclinical oncology biotech Foghorn Therapeutics sets terms for $120 million IPO  renaissancecapital.com

FHTX IPO News - Preclinical oncology biotech Foghorn Therapeutics sets terms for $120 million IPO - renaissancecapital.com

Click here to get full coverage on Top Foghorn Therapeutics (FHTX) Competitors 2026 - MarketBeat

Top Foghorn Therapeutics (FHTX) Competitors 2026  MarketBeat

Top Foghorn Therapeutics (FHTX) Competitors 2026 - MarketBeat

Click here to get full coverage on Cigall Kadoch Net Worth (2026) - GuruFocus

Cigall Kadoch Net Worth (2026)  GuruFocus

Cigall Kadoch Net Worth (2026) - GuruFocus

Click here to get full coverage on Foghorn Therapeutics Announces Pricing of Initial Public Offering - GlobeNewswire

Foghorn Therapeutics Announces Pricing of Initial Public Offering  GlobeNewswire

Foghorn Therapeutics Announces Pricing of Initial Public Offering - GlobeNewswire

Click here to get full coverage on Michael Mendelsohn Net Worth (2026) - GuruFocus

Michael Mendelsohn Net Worth (2026)  GuruFocus

Michael Mendelsohn Net Worth (2026) - GuruFocus

Click here to get full coverage on FHTX PE Ratio & Valuation, Is FHTX Overvalued - Intellectia AI

FHTX PE Ratio & Valuation, Is FHTX Overvalued  Intellectia AI

FHTX PE Ratio & Valuation, Is FHTX Overvalued - Intellectia AI

Click here to get full coverage on FHTX Should I Buy - Intellectia AI

FHTX Should I Buy - Intellectia AI

Click here to get full coverage on FHTX Technical Analysis & Stock Price Forecast - Intellectia AI

FHTX Technical Analysis & Stock Price Forecast  Intellectia AI

FHTX Technical Analysis & Stock Price Forecast - Intellectia AI

Click here to get full coverage on Foghorn Therapeutics (FHTX) Stock Forecast & Price Prediction 2026–2030 - CoinCodex

Foghorn Therapeutics (FHTX) Stock Forecast & Price Prediction 2026–2030  CoinCodex

FHTX

Price Chart

Key Statistics

Technicals

About FHTX

Latest News

If You Invested $1,000 in Foghorn Therapeutics Inc. (FHTX) - Stock Titan

Foghorn Therapeutics Inc. (NASDAQ:FHTX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

FHTX Stock Price, Quote & Chart | FOGHORN THERAPEUTICS INC (NASDAQ:FHTX) - ChartMill

Advanced Charts

Top Gainers

Top Losers